A clinically-oriented computer model for radiofrequency ablation of hepatic tissue with internally cooled wet electrode by Ewertowska, Elzbieta et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=ihyt20
International Journal of Hyperthermia
ISSN: 0265-6736 (Print) 1464-5157 (Online) Journal homepage: http://www.tandfonline.com/loi/ihyt20
A clinically oriented computer model for
radiofrequency ablation of hepatic tissue with
internally cooled wet electrode
E. Ewertowska, R. Quesada, A. Radosevic, A. Andaluz, X. Moll, F. García Arnas,
E. Berjano, F. Burdío & M. Trujillo
To cite this article: E. Ewertowska, R. Quesada, A. Radosevic, A. Andaluz, X. Moll, F. García
Arnas, E. Berjano, F. Burdío & M. Trujillo (2018): A clinically oriented computer model for
radiofrequency ablation of hepatic tissue with internally cooled wet electrode, International Journal
of Hyperthermia, DOI: 10.1080/02656736.2018.1489071
To link to this article:  https://doi.org/10.1080/02656736.2018.1489071
© 2018 The Author(s). Published with
license by Taylor & Francis Group, LLC.
Published online: 08 Oct 2018.
Submit your article to this journal 
View Crossmark data
A clinically oriented computer model for radiofrequency ablation of hepatic
tissue with internally cooled wet electrode
E. Ewertowskaa,, R. Quesadab , A. Radosevicc, A. Andaluzd, X. Molld, F. Garcıa Arnasd , E. Berjanoa ,
F. Burdıoe and M. Trujillof
aBioMIT, Department of Electronic Engineering, Universitat Politecnica de Valencia, Valencia, Spain; bDepartment of Experimental and
Health Sciences, Universitat Pompeu Fabra, Parc de Recerca Biomedica de Barcelona, Barcelona, Spain; cDepartment of Radiology, Hospital
del Mar, Barcelona, Spain; dDepartament de Medicina i Cirurgia Animals, Facultat de Veterinaria, Universitat Autonoma de Barcelona,
Barcelona, Spain; eDepartment of Surgery, Hospital del Mar, Barcelona, Spain; fBioMIT, Department of Applied Mathematics, Universitat
Politecnica de Valencia, Valencia, Spain
ABSTRACT
Purpose: To improve the computer modelling of radiofrequency ablation (RFA) by internally cooled
wet (ICW) electrodes with added clinically oriented features.
Methods: An improved RFA computer model by ICW electrode included: (1) a realistic spatial distribu-
tion of the infused saline, and (2) different domains to distinguish between healthy tissue, saline-infused
tumour, and non-infused tumour, under the assumption that infused saline is retained within the
tumour boundary. A realistic saline spatial distribution was obtained from an in vivo pig liver study. The
computer results were analysed in terms of impedance evolution and coagulation zone (CZ) size, and
were compared to the results of clinical trials conducted on 17 patients with the same ICW electrode.
Results: The new features added to the model provided computer results that matched well with the
clinical results. No roll-offs occurred during the 4-min ablation. CZ transversal diameter (4.10±0.19 cm)
was similar to the computed diameter (4.16 cm). Including the tumour and saline infusion in the
model involved (1) a reduction of the initial impedance by 10 20X, (2) a delay in roll-off of 20 s and
70 100 s, respectively, and (3) 18 31% and 22 36% larger CZ size, respectively. The saline spatial
distribution geometry was also seen to affect roll-off delay and CZ size.
Conclusions: Using a three-compartment model and a realistic saline spatial distribution notably
improves the match with the outcome of the clinical trials.
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1. Introduction
Radiofrequency ablation (RFA) is a minimally invasive proced-
ure that destroys tumours by selective heating with radiofre-
quency (RF) electrical current [1,2]. RF current produces ionic
agitation in the tissue next to the electrode, which is trans-
formed into heat and propagated in the tissue by thermal
conduction [3]. A few seconds after the tissue reaches a tem-
perature over 50 C, the cell proteins are denatured and the
cell dies by coagulative necrosis [4,5]. To guarantee the
destruction of tumour cells, RFA must produce a successful
coagulation zone (CZ) around the tumour with a 5–10mm
surgical margin recommended for inhibition of local recur-
rence caused by residual untreated single tumour cells [6].
Although tissue impedance is reduced when heating starts,
the dehydration around the electrode due to the liquid-to-
vapour phase change causes a sudden rise in electrical
impedance (roll-off). This phenomenon seriously limits
energy deposition in the tissue and reduces CZ size. Changes
in the power delivery protocol and electrode design have
been the primary ways of overcoming this limitation.
Internally cooled wet (ICW) electrodes, with combined
saline infusion and internal electrode cooling, have arisen as
an alternative method of increasing the CZ size obtained
separately by cooled electrodes and wet electrodes [7]. The
combination of tissue hydration and higher tissue electrical
conductivity by infused hypertonic saline, together with the
effect of internal cooling, keeps impedance low for longer
and may even eliminate roll-off [8–10]. This increases CZ size,
and hence the ability to treat larger tumours. Previous
experimental and computational results have shown that
larger CZs can be obtained by ICW electrodes than by cooled
electrodes and wet electrodes separately [11–13], while even
larger CZs can be obtained if saline is infused 2mm from the
mid-point of the electrode tip [14]. This “remote” infusion is
physically implemented by expandable infusion needles.
Unfortunately, saline infusion may involve potential risks,
such as uncontrolled saline migration in tissue (although this
is less likely in the case of encapsulated tumours) or irregular
CZs [15]. Accidental perforation of the tumour wall by
expandable infusion needles could also damage nearby
organs by saline leakage or undesirable tumour cell seeding.
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Computational modelling can provide a comprehensive
and detailed biophysical description of the electrical and
thermal performance of ICW electrodes during RFA, and thus
can be used to improve their use in clinical practice.
However, as far as we know, there is still a gap between the
modelling studies in this field and their transfer to clinical
practice [8,13,16–18]. Demazumder et al. [16] and Antunes
et al. [18] built computational models of wet electrodes for
cardiac and hepatic RFA, respectively, while Romero-Mendez
et al. [8] compared the electrical and thermal behaviour of
wet electrodes with ICW electrodes. However, all the phe-
nomena associated with saline infusion have not yet been
thoroughly studied. Although Qadri et al. [17] proposed a
computational model of ICW electrodes that included saline
transport through the tissue, neither the ICW electrode
model nor the ablation protocol (10min-RFA at constant
90 C by varying input voltage) matched the real conditions
of clinical practice.
As an alternative to the formulation proposed by Qadri
et al. [17], we recently conducted a study of the influence on
CZ size of all the phenomena involved in RFA by ICW elec-
trodes and how they could be included in a computational
model [13]. The results showed that the higher electrical con-
ductivity due to saline infusion was mainly responsible for
the better performance of ICW electrodes over internally
cooled (IC) electrodes, especially as regards CZ size and
delaying roll-off. However, this model had two limitations
which prevented the computational results being extrapo-
lated to clinical practice: (1) the spatial distribution of infused
saline was assumed to be spherical, which does not always
actually occur; and (2) the electrical, thermal and perfusion
characteristics of healthy and tumour tissue were assumed to
be identical, even though electrical conductivity is known to
be much higher in tumours than in healthy tissue, and blood
perfusion in tumours varies as they grow.
Our aim was thus to improve the previous computational
model [13] and set up a clinically oriented model which
would include: (1) a more realistic pattern of infused saline
distribution at the centre of the tumour based on the results
of an ad hoc in vivo experiment, and (2) three compartments
for the different zones of saline-infused tumour, non-infused
tumour and healthy tissue. The computer results (CZ size
and evolution of impedance) were compared to those
obtained from a clinical trial with an ICW electrode with
identical characteristics to those of the modelled electrode.
2. Materials and methods
2.1. Clinical trial
A randomised clinical trial comparing RF ablation (with ICW
electrode) vs. microwave ablation (European Registry
ISRCTN73194360) is currently under way in the Hospital del
Mar (Barcelona, Spain). In the context of our modelling study,
we selected and analysed only those nodules treated with a
single RF ablation from May 2014 to April 2017, which
involved 17 patients and a total of 19 nodules measuring
17.9 ± 0.8mm in major diameter and 14.8 ± 0.8mm and
12.8 ± 0.7mm in minor diameters. RFA was performed using
an ICW electrode comprised of a single 2.8mm diameter and
30-mm long internally cooled electrode with two electrically
isolated expandable needles (0.65mm outer diameter) to
infuse hypertonic (20% NaCl) saline at 2mm from the elec-
trode surface [19] (see Figure 1(a,b)). The electrode tempera-
ture was kept under 10 C by cooled saline circulating
through the electrode at 100mL min1. RF energy was deliv-
ered for 4min by a CC-1 generator (Radionics, Burlington,
MA). The impedance control mode used consisted of a 1-min
ramp-up phase followed by 3min at maximum power
(140W). Power was supplied from the ICW electrode to
four dispersive electrodes.
As saline is normally infused during RFA with ICW electro-
des, this demands that the optimal volume of injected saline
must be used, as an excess can lead to leaks, irregular
morphology of the ablated zones (due to hot saline) or seed-
ing of tumour cells carried by the saline [20]. Alternatively,
pre-treatment with a hypertonic saline bolus (instead of con-
tinuous infusion) could provide a controlled dose of fluid
and hence would reduce the risk of complications. The clin-
ical trial thus employed two boluses of 0.5mL of saline each
infused simultaneously through both expandable needles
just before RFA. Two additional boluses were administered
Figure 1. (a) Internally cooled-wet (ICW) electrode used in the clinical trial. (b) Electrode scheme and dimensions (in mm, out of scale). Blue arrows indicate the
internal flow of cooling liquid while red arrows show the outflow of hypertonic saline through expandable needles. (c) Geometry of the three-compartment model
used in the computational study. Note that the geometry of infused tissue is for illustrative purposes only, i.e. it does not coincide with the contour geometry of
saline-infused tissue computed from the “generic pattern” (shown in Figure 2(b,c), respectively).
2 E. EWERTOWSKA ET AL.
for <15 s after 90 s of RFA for additional rehydration of the
overheated tissue to prevent any potential rise in tissue
impedance. Both impedance and power evolution were
recorded throughout the ablation. After the procedure com-
puter tomography scans were used to measure the diame-
ters of the coagulation zones, which were “corrected” by
taking the shrinkage phenomenon into account prior to
comparing the measurements with the computer results (see
2.3. Computational model).
2.2. Spatial distribution of infused saline measured by
in vivo study
The spatial distribution of the saline infused into the tissue
by the boluses was analysed by means of an in vivo experi-
mental study on two female pigs. The study was approved
by the Animal and Human Experimentation Ethics
Committee of the Universitat Autonoma de Barcelona (proto-
col numbers CEEAH 3336 and DMAH 8904). Both animals
underwent a laparotomy to expose the liver for direct infu-
sion. Iopamidol, a non-ionic contrast agent (G.E.S., Madrid,
Spain), was added to the infused saline. The boluses were
introduced into different sections of each lobe through the
two expandable needles of an ICW electrode identical to
that used in the clinical study. Six sets of infusions were
made, each consisting of two 0.5mL boluses injected at 0 s
and 90 s, which gives 2mL total volume injected per set.
Each infusion took 15 s. The spatial distribution of infused
saline was mapped by a GE OEC Fluorostar fixed X-ray image
intensifier system (GE OEC Medical Systems, Salt Lake City,
USA) without applying RF, since the aim was to determine
the spatial distribution of the saline bolus just before RFA.
The images were first preprocessed with Image J Software
(open source available at https://imagej.net), adjusting
brightness and contrast in order to reduce noise and
enhance image quality. As the images from the first and
second infusion of the same set were seen to have an almost
identically shaped and sized distribution (see Results section
for further details), they were overlapped to create a “generic
distribution” for each set. The margins of the infused areas
were then segmented by thresholding each 8-bit greyscale
image [21], preceded by the background subtraction oper-
ation for increased effectiveness. The segmented margins
were then merged with the original images, converted into
binary format and mounted together to create one greyscale
image in which each image made up 16.6% of the total
greyscale intensity, so that 67% greyscale was considered as
the “generic pattern” of saline infusion and hence was used
to build the computer model.
2.3. Computational model
2.3.1. Geometry
The computational model mimicked an RF hepatic ablation
by ICW electrode, as shown in Figure 1(a,b). The dispersive
electrode was modelled as an electrical condition on the
boundaries parallel to the active electrode axis. The area of
these boundaries coincided with those of four dispersive
electrodes (132 cm2 each). Figure 1(c) shows the model
geometry, which consisted of five domains with different
characteristics: healthy tissue, non-infused tumour, saline-
infused tumour, metallic components (electrode, expandable
infusion needles) and plastic component (sheath). The outer
boundaries of the healthy tissue domain formed a 60-mm
radius and 150-mm long cylinder. These dimensions,
obtained from a sensitivity analysis, guaranteed an adequate
distance between the ICW electrode and the boundary con-
dition (mimicking the dispersive electrodes) to avoid any
effects on the simulation results. The reference parameter for
the sensitivity analysis was the maximum temperature (Tmax)
reached after 240 s at five points at <1mm from the ICW
electrode. The former dimensions were used in the model
for differences in electrode Tmax of <0.5% between two sub-
sequent simulations. As the three-dimensional geometry pre-
sented two symmetry planes (see Figure 1(c)), the computer
model only considered one-quarter of the complete geom-
etry. The tumour dimensions were based on the nodule size
reported in the clinical study (see Section 2.1 Clinical trial).
The tumour was assumed to be an ellipse with major axis
(axial diameter) of 18.7mm and with minor axis (transversal
diameter) of 15.6 mm. The geometry of the spatial distribu-
tion of infused saline matched with the “generic pattern”
obtained from the experimental in vivo study (see Section
3.2. Saline spatial distribution) and was centred and enclosed
inside the tumour. This correlated with the assumption that
saline accumulates inside a tumour with a limited volume
due to the surrounding fibrous capsule. Any excess saline
injected into a tumour could result in saline reflux and leak-
age around the infusion needle [20,22,23].
2.3.2 Governing equations and conditions
The model was based on a coupled electric-thermal problem,
which was solved numerically on COMSOL Multiphysics soft-
ware (COMSOL, Burlington, MA). The governing equation for
the thermal problem was the Bioheat equation [24] modified
by the enthalpy method to include water vaporisation [25]:
@ qhð Þ
@t
¼ r  krTð Þ þ qþ Qp þ Qm (1)
where q is tissue density, h enthalpy, T temperature, t time, k
thermal conductivity, q heat source produced by RF power,
Qp heat loss by blood perfusion and Qm the metabolic heat
generation. Qm was not considered since it is negligible in
RFA. No convection term associated with saline motion was
considered since its effect is negligible [13].
The heat source produced by RF power (Joule losses) was
given by q¼ rjE j 2, where E is the electric field. E¼rV
was obtained from the governing equation of the electrical
problem r(r(T)rV)¼0, r being the electrical conductivity
and V the voltage. The electrical conductivity of the tissues
was assumed to be a temperature-dependent piecewise
function: an exponential increase by þ1.5%/C up to 99 C,
the value was kept constant between 99 and 100 C, then
reduced two orders for five degrees, and remained constant
for temperatures above 105 C. The value of r was specified
for all the tissue subdomains considered at a reference
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temperature (see Tissue characteristics subsection). We used a
quasi-static approach as it is known that the resistive current
at RF (500 kHz) is much lower than the displacement cur-
rent [26].
The blood perfusion term Qp was obtained from:
Qp ¼ bqbcbxb TbTð Þ (2)
where xb is the blood perfusion coefficient, qb and cb are
the blood density and specific heat, respectively, Tb is the
temperature of the arterial blood (37 C) and b is a coeffi-
cient that modifies blood perfusion with tissue damage. The
thermal damage was assessed by the Arrhenius damage
model [27], which associates temperature with exposure
time by a first-order kinetics relationship:
X tð Þ ¼
ðt
0
Ae
DE
RT ds (3)
where X is the damage function, R is the universal gas con-
stant, A is a frequency factor and DE is the activation energy
for the irreversible damage reaction. The value of X¼ 4.6
corresponding to a 99% probability of cell death [28] was
used to define the coagulation zone. Accordingly, blood per-
fusion rate was defined as follows: b¼ 0 for X 4.6, and
b¼ 1 for X< 4.6.
Considering tissue hydration due to saline infusion and
vaporisation at temperatures above 100 C, the first term in
Equation (1) can be expressed in biological tissues as [13,25]:
@ qhð Þ
@t
¼ @T
@t

ql cl
FhfgC
qgcg
0<T  99C
99<T  100C
T>100C
8<
: (4)
where q and c are tissue density and specific heat respect-
ively at temperatures of 100 C (i¼ l refers to water in liquid
phase) and above (i¼ g refers to water in gas phase), and hfg
is the product of water latent heat and water density at
100 C, C is tissue water content, and F is a factor previously
proposed by the authors which expresses the requirement
for more energy at the phase change when considering
saline infusion, in addition to the water already contained in
the tissue [13].
The thermal boundary conditions were: initial tissue tem-
perature and temperature at all the outer boundaries of
37 C, and null heat flux on the two symmetry planes. The
cooling effect of the liquid circulating inside the electrode
was modelled using a thermal convection coefficient h with
a value of 2,800WK1m2 and a coolant temperature of
10 C. The value of h was calculated for a flow rate of
100mLmin1 through an area estimated as half of the
internal area of the active electrode (see Figure 1(b)).
Electrical boundary conditions were: no current flow in the
symmetry planes and on the top and bottom liver bounda-
ries, and voltage set to zero on the remaining boundary to
model the dispersive electrode. Power application mimicked
the clinical protocol as far as possible: the voltage of the
ICW electrode was linearly increased from 0 to 74 V during
the first 60 s and was then kept constant for the remaining
3min, which corresponded with 140W power.
2.3.3. Solver
The model mesh size was predefined by COMSOL at
9.38mm, although additional refinement with 0.6mm elem-
ent size was used next to the ICW electrode, where the max-
imal electric and thermal gradients occur. The sensitivity
study (as previously described for model dimensions) was
performed on mesh size to find an adequate spatial discret-
ization and minimise its effect on the numerical solution. An
adaptively changing time step was used. Again, we assessed
the time-step suitability by an analogous sensitivity analysis.
2.3.4. Tissue characteristics
Table 1 shows the parameter values used in the model
[29–41]. Healthy liver electrical conductivity (r) was set to
0.2 Sm1 at a reference temperature of 37 C, within the
range of values reported in the literature: 0.132 Sm1 [29],
0.143 S/m [30] and 0.260 S m1 [42]. Although a tumour elec-
trical conductivity value of 0.5 Sm1 had been used previ-
ously [20,30,31,42,43], 0.45 Sm1 was chosen so that the
computed initial impedance evolution matched the values
found in the clinical trials (Section 3.1 Clinical results).
Saline-infused tumour was characterised by higher elec-
trical conductivity due to the increased concentration of ions
in the saline, which carry the electric charge. According to
Goldberg et al. [23], tissue “doped” with 18% hypertonic
saline showed almost half the impedance measured before
the injection (110 X before and 64 X after). This can only
be due to higher electrical conductivity, and so the electrical
conductivity was twice that of non-infused tissue: 0.4 Sm1
for saline-infused healthy liver and 0.9 Sm1 for saline-
infused tumour. This assumption led to lower initial tissue
impedance and matched the clinical values (see Section 3.1
Clinical results).
Table 1. Characteristics of the materials used in the computational model (references in brackets).
Plastic Metal Healthy liver Noninfused tumour Saline-infused tumour
Electrical conductivity (S m1) 105 [34] 7.4106 [35] 0.2 0.45 0.9
Thermal conductivity (W m1 K1) 0.026 [35] 15 [35] 0.502 [36] 0.5 [32] 0.5 [32]
Density (kg m3) LP 70 [35] 8103 [35] 1080 [29] 1045[31] 1045 [31]
GP 370 [29] 370 [29] 370 [29]
Specific heat (J kg1 K1) LP 1045 [35] 480 [35] 3455 [29] 3760 [31] 3760 [31]
GP 2156 [29] 2156 [29] 2156 [29]
Water content (%) 68 [37] 84 [38, 39] 84 [38, 39]
Frequency factor (s–1) 7.391039 [40] 5.3161050 [41] 5.3161050 [41]
Activation energy (J mol1) 2.577105 [40] 3.238105 [41] 3.238105 [41]
Blood perfusion (s–1) 0.016 [30] 0.009 [30, 33] 0.009 [30, 33]
Electrical conductivity of tissue was measured at 37 C; LP: water in liquid phase; GP: water in gas phase.
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Values of tumour density (q) and specific heat (c) when its
water content is in the liquid phase (T< 100 C) were taken
from [29] and [31]. However, as to our knowledge there are
no references for the value of tumour density and specific
heat when its water content is in the gas phase in Equation
(4), we assumed the same values as liver, due to their similar-
ity in this state and their slight influence on the results [44].
As tumour blood perfusion coefficient (xb) has been
reported within a wide range of values: 0.0027 s–1 [32],
0.0053 s–1 [43], 0.0069 s–1 [45], 0.0096 s–1 [33], 0.011 s–1
(63.8mL/100g min1, [46]) and 0.009 s–1 (510mL kg1 min1,
[30]), we chose a value of 0.009 s–1 as it was the reference
we used for healthy tissue and agreed with Aramburu et al.
[45], who suggested that perfusion in healthy tissue is differ-
ent from that of tumour tissue. While healthy tissue is sup-
plied through the portal vein and hepatic artery, a tumour is
exclusively supplied from the hepatic artery, which could
mean the blood perfusion rate is higher in healthy tissue
than in the tumour. We therefore used a value of 0.016 s–1
for healthy tissue, which has also been also reported in the
literature [30]. According to Hall et al. [44] the perfusion
coefficient has a strong impact on the model results, so we
decided to conduct a sensitivity analysis of xb values for
tumour (Case F) ranging from 0.0027 s–1 to 0.011 s–1.
Factor F in Equation (4) was set to 1 for both non-infused
liver and tumour. For the saline-infused tumour we used a
value of F¼ 3 obtained by a sensitivity analysis, as suggested
in [13], which related the given value with the process of tis-
sue hydration. F was an adjusting parameter for energy at
the phase change during water evaporation when consider-
ing saline infusion, as it is assumed that additional tissue
hydration increases the tissue’s heat capacity. As the only
references for characterising saline-infused tumour, deal with
its electrical conductivity, we used the same material charac-
teristics as for non-infused tumour.
2.3.5. Cases analysed
The aim of this study was to improve a previously proposed
computational model [13] by including two clinically ori-
ented characteristics: (1) a more realistic spatial distribution
of infused saline, and (2) new geometry with three separate
compartments for healthy liver, noninfused tumour and
saline-infused tumour. To assess the influence of these two
characteristics on the results, the following five cases were
solved and their results compared:
- Case A: One-compartment model considering only non-
infused healthy tissue (for an IC electrode).
- Case B: Two-compartment model consisting of nonin-
fused and infused zones of healthy tissue, assuming spatial
distribution to be spherical [13].
- Case C: Two-compartment model as in B but using the
“generic pattern” of saline distribution obtained from the in
vivo experiments.
- Case D: Two-compartment model consisting of non-
infused healthy liver and tumour tissue.
- Case E: Three-compartment model consisting of healthy
tissue, non-infused and infused tumour with the spherical
saline distribution as in Case B.
- Case F: Three-compartment (full) model consisting of
healthy tissue, noninfused tumour and infused tumour with
the “generic pattern” of saline infusion obtained from the in
vivo experiments.
2.3.6. Outcomes
Impedance evolution throughout ablation was analysed for
each case, as was transverse CZ diameter at roll-off or other-
wise at 240 s. The CZ computed by the Arrhenius damage
model at 4min produced a “very noisy” contour. According
to Schutt et al. [28], when computing the lesion dimension
contour, the 48 – 50 C isotherm correlates with the D99 ther-
mal damage contour, which corresponds to X¼ 4.6 (99%
probability of cell death) after a 12min protocol. In the pre-
sent study we verified that after 4min of ablation the 50 C
isotherm matched with X¼ 4.6 (with variations <2mm) but
the isotherm traced a more regular line, so that the 50 C
isotherm was used to measure CZ diameter. Obviously, the
use of the isotherm impedes computing the thermal damage
accumulated during the cooling phase (just after RF power is
switched off), although it is known that the difference in CZ
size before and after the cooling phase is negligible in long
ablations [47]. Because of the shrinkage associated with RFA,
CZ size as measured in clinical practice could be up to
12–20% smaller [48,49]. According to Schutt et al. [28] and
Rossmann et al. [48], it is preferable to compare computa-
tional results with those obtained in the clinical trials before
shrinkage. We therefore established a 20% bigger CZ size
margin than the clinical trial when comparing the computer
model results.
3. Results
3.1. Clinical results
A maximum output power (140W) was applied to the tissue
after a 1min ramp-up, which implied 30 kJ of total energy
deposited. The initial impedance value was 55X, and
dropped to a value of 46 ± 6X just after saline infusion and
kept more or less constant throughout the ablation (plateau
phase). No roll-off was registered in the whole period. The
measured CZ diameters were 3.42 ± 0.16 cm and
2.81 ± 0.16 cm (maximum and minimum transverse diameters,
respectively) and 4.71 ± 0.19 cm (axial diameter). After dis-
carding the shrinkage effect and considering 20% larger
diameters, these values were: 4.10 ± 0.19 cm and
3.37 ± 0.19 cm (maximum and minimum transverse diameters,
respectively) and 5.65 ± 0.23 cm (axial diameter).
3.2. Saline spatial distribution
The six sets of infusions gave a total of 12 saline distributions
(one per each infusion needle). In most cases (10/12), during
the injection of the first bolus, X-ray images showed the
saline gradually occupying the space around the needle out-
let, until a volume of infused tissue was formed. After the
injection, the intensity of the contrast agent associated with
the saline presence was seen to drop steadily for 90 s, but
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did not completely disappear. The shape of the infused vol-
ume remained unchanged during this period. During the
administration of the second bolus, the intensity was grad-
ually restored and the shape contour expanded slightly, after
which the intensity and shape evolution were similar to
those of the first injection.
In a few cases (2/12) the X-ray images showed that the
infused saline escaped through preferential paths and could
not accumulate around the infusion needle. These paths cor-
responded with nearby vessels, whose presence significantly
weakened the intensity associated with the contrast agent.
As the same procedure occurred after the second bolus both
cases were discarded in the analysis. In the remainder (10/
12) the saline distribution was irregular and mostly
accumulated close to the expandable needle outlet. Figure
2(a) shows the overlapped images of saline distribution
obtained from the six sets of saline injections used to obtain
the “generic pattern” shown in Figure 2(b).
The contour geometry used in the computer model was
derived from this “generic pattern” and revolved symmetric-
ally to the rotation axis (Figure 2(c)). The total volume of
saline estimated from the computer model was close to the
total volume injected during each in vivo experiment (1.62
and 2mL, respectively). This volume was used to estimate
the radius of the saline spherical distribution considered in
Cases B and E.
3.3. Computational results
3.3.1. Impedance evolution
Figure 3 shows the impedance evolution for each analysed
case. Roll-off was earlier in cases without saline infusion (A
and D), while the addition of saline involved a delay of
around 70 100 s (B and C). Roll-off occurred earlier in Case
B, with spherical distribution, even though both cases con-
sidered the same saline volume. Although including the
tumour involved a delay in roll-off (see case A vs. D), its
effect was not as marked as saline infusion. In contrast, no
roll-offs occurred when both saline infusion and tumour
were included (E and F).
Comparing the cases with and without saline infusion (B,
C, E and F vs. A and D), infusion was seen to reduce the ini-
tial impedance from 69X to 60X in the cases considering
only healthy tissue (A vs. B and C) and from 56X to 50X in
the cases including the tumour (D vs. E and F). In other
words, saline infusion reduced the initial impedance by
10 13%. Comparing the cases with and without the
tumour (A, B and C vs. D, E and F), when the tumour was
Figure 2. (a) Images of saline spatial distribution from the six saline injection trials (1 – 6) conducted on the in vivo model. Saline presence is shown in white, while
electrode, infusion needles and noninfused tissue are in black. (b) “Generic pattern” of saline spatial distribution derived from the six images from (a) by threshold-
ing and merging them into one greyscale image. (c) Contour geometry of saline-infused tissue derived from the “generic pattern” in (d) and used in the com-
puter model.
Figure 3. Impedance evolution in the six analysed cases: A (one-compartment
model, only liver), B (two-compartment model, with liver and saline-infused
liver using the saline distribution with spherical geometry as proposed in [13]),
C (two-compartment model, with healthy liver and saline-infused healthy liver
using the saline spatial distribution obtained from the in vivo experiment), D
(two-compartment model, with non-infused healthy liver and tumour), E (three-
compartment model, with healthy liver, tumour with noninfused and saline-infused
zones, and spherical geometry infusion) and F (three-compartment model, with
healthy liver, tumour with noninfused and saline-infused zones, and saline spatial
distribution obtained from the in vivo experiment). The horizontal grey band repre-
sents the range of impedance values observed in the clinical trial. Roll-off time is
shown for cases A, B and D.
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included the initial impedance was reduced from 69 to 56X
for non-infused tissue (A vs. D) and from 60 to 51X for
saline-infused tissue (C vs. E and F), showing that the pres-
ence of the tumour reduced initial impedance by 15 – 18%.
Because of the delay in roll-off, the cases that considered
both saline infusion and tumour (E and F) had the longest
plateau phase, with impedance values more or less constant
and within 32 50 X, and even up to the end of ablation in
Case E. Interestingly, the case with the saline distribution
based in the “generic pattern” (F) showed values closer to
those observed in the clinical trials.
3.3.2. Joule heat source distribution
Figure 4 shows the comparison of the Joule heat source dis-
tributions in cases A–F at the beginning of ablation, at 1 s.
As expected, the highest Joule heating concentration was
seen in close proximity to the electrode and reached its max-
imum at both ends of its active part. Although the metal
infusion needles were not part of the active electrode (since
they are not electrically connected to it), there was a notice-
able accumulation of power distribution along their length.
Higher power intensity (values 109Wm3) was also
observed in Cases B–F along the boundaries of the tumour
and saline domains, although it was slightly lower within
these domains (107W m3).
3.3.3. Coagulation zone size
Figure 5(a) shows the temperature distributions, CZ contour
(assessed by the 50 C isotherm), 100 C isotherm, and the
values of transversal CZ diameter for the six analysed cases.
The largest transversal CZ diameters were observed when
saline infusion was considered. The diameter increased from
2.60 cm to 3.54 3.60 cm in healthy tissue (A vs. C and B,
respectively) and from 3.40 cm to 4.16 4.34 cm in the
tumour (D vs. F and E, respectively). Although all the cases
showed a similar CZ shape, saline infusion increased the
transversal CZ diameter by 37% in healthy tissue and 25% in
tumour tissue.
Including the tumour as a single factor also increased the
transversal CZ diameter by 31% in noninfused tissue (A vs.
D) and 18 20% in saline-infused tissue (B vs. E and C vs. F).
Interestingly, the results showed that including either saline
infusion (B and C) or tumour (Case D) produced a similar
increase in the transversal CZ diameter. As a logical conse-
quence, the largest transversal CZ diameter was obtained
when both characteristics (saline infusion and tumour) were
considered together (E and F).
3.3.4. Effect of tumour blood perfusion
The analysis of the effect of different tumour blood perfusion
values (xb) on the three-compartment model (Case F)
showed that in 240 s of ablation roll-off appeared only when
the xb value was the lowest of the chosen range (0.0027 s
–1).
For higher blood perfusion values used it was assumed that
roll-off would occur after 240 s and would depend on the xb
value. CZ growth during the 240 s ablation in all the models
was practically unchanged for different xb values (differences
<1%), showing that increasing the xb value did not directly
increase CZ size but could delay roll-off.
3.4. Comparison of clinical and computer results
Figure 6 shows the transversal CZ diameters obtained from the
computer results and clinical trials. The coloured band repre-
sents a range between a minimum value which considers the
tissue shrinkage effect and a minimum value that does not, or
the probable range in which the results of the computer model
(which did not consider the shrinkage effect during ablation)
could be compared to the results of the clinical trials. It can be
seen that only the cases that included both saline infusion and
the tumour (E and F) predicted a higher transversal diameter
than the minimum value. Only Case F was strictly within the
diameter range and therefore the only case with similar results
to those of the clinical trials.
4. Discussion
This study was designed to go a step further in RFA com-
puter modelling by ICW electrode. The desired improvement
was to be obtained by including two clinically oriented char-
acteristics: a more realistic geometry of the infused saline
Figure 4. Joule heat distribution in the tissue for cases A–F at 1 s of ablation, (logarithmic scale in W/m3). Note that maximum values are reached only on the elec-
trode surface and the infusion needles.
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spatial distribution and assigning specific characteristics to
infused and non-infused tumour zones.
First of all, an in vivo study was performed on healthy
porcine liver to determine saline spatial distribution after a
bolus injection. Two results were obtained, possibly depend-
ing on the tissue morphology around the infusion point.
First, when the infusion point was at a certain distance from
a vessel, the parenchyma retained a certain amount of saline
around that point, at least at the infusion rate employed
here (1mL for 15 s). The space occupied probably depended
on the bolus volume. The gradual decrease in image inten-
sity indicates that there is a slow loss of accumulated
volume, which suggests that the tissue morphology allows
the saline to migrate away, possibly through central veins.
This suggests that some saline is still present prior to the
second bolus and it is hence reasonable to assume that just
after the second injection there will be between 1 and 2mL
of saline around the needle. For this reason, the estimated
1.62mL of total volume of infused saline in the computer
model can be said to be consistent.
Second, when the infusion point was near a vessel the
results suggested that the vessel acted as a preferential
saline drainage path. Under these conditions, no saline
would be retained around the infusion point and the tissue
would not be rehydrated during RFA.
The “generic pattern” used to build the computer model
geometry was based in the most probable scenario, i.e. that
allowing saline to accumulate around the infusion point. In
fact, although the saline distributions indicated dispersion
between the injections, the “generic pattern” matched 67%
of the observed cases, showing irregular borders around the
electrode and infusion needles, possibly due to heteroge-
neous permeability caused by the presence of branching
networks of blood and lymphatic vessels [50].
The thin laceration gap during electrode insertion
between the tissue and metal components (infusion needles
and electrode) could also form an additional preferential
saline drainage path. However, this behaviour was not found
Figure 5. a: Temperature profiles of cases A–E. Black and white contours are 50 C and 100 C isotherms, respectively. The transversal diameter value and time of
acquisition are shown in all cases at roll-off times before 240 s or at 240 s in the absence of roll-off. b: Detail of electrode zone in (a) with 100 C white iso-
therm shown.
Figure 6. Transversal diameters of the coagulation zones computed for the
considered cases A–F. Horizontal lines are the mean transversal diameter found
in the clinical trials (dashed line) and the “corrected value” by taking the shrink-
age effect into account (dotted line). The coloured band thus represents the
range in which the clinical and computed results would match.
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during the study, nor did we find any previous publications
reporting this issue. This phenomenon was therefore dis-
carded in the model. The in vivo study thus suggests that
saline mainly accumulates around the needle outlets in an
oval-like geometry with the largest diameter in the direction
of the electrode axis. Because it is reasonable to assume that
saline distribution during RFA would be different in the pres-
ence of a tumour (see Limitations), the “generic pattern”
employed to build the geometry of the computer model
should be considered an approximation.
The computer results showed that modifying the simplest
model (Case A) to include a second compartment (tumour or
infused zone) reduced the initial impedance. This can be
explained by the electrical conductivity of both saline and
tumour being higher than non-infused healthy tissue. This
also meant that for the same RFA protocol the initially
applied power in Cases B, C and D was 20W higher than
A, which could have been responsible for the larger CZ in
those cases. However, the authors consider that the most
important factor in CZ growth is the delay in roll-off: 23.5 s
when the tumour is included (D vs. A) and up to 72.3 and
98.6 s when an infused tissue zone is considered (B and C vs.
A). The larger CZ size due to only including the tumour in
the model has already been reported by Ahmed et al. [32],
although in the present study the greatest effect was related
to saline infusion, and hence to tissue hydration, by includ-
ing factor F in the mathematical framework. This factor is
simply an adjusting parameter which allows an energy
increase to be considered at the phase change in response
to additional tissue hydration by saline infusion, which
increases the tissue’s heat capacity. This, in addition to the
increase of electrical conductivity, explains the long roll-off
delays. Two-compartment models thus predict larger CZs
than models based exclusively on healthy tissue.
One of the innovations of this study was to include a spe-
cific geometry for the infused saline zone based on the
results of an in vivo study. Despite the limitations involved,
we considered this to be the most plausible representation
of the spatial distribution of saline in the tissue. As compared
to a spherical distribution [13], the geometry derived from
the “generic pattern” (Case C) extended roll-off time by 26 s.
Because both geometries involved the same total saline vol-
ume, the delay could be explained by the particular geom-
etry of case C, which tends to completely surround the
electrode, extending toward the ends in an elongated shape,
in contrast to the spherical geometry in Case B. The elec-
trode ends (tip and proximal edge) are associated with the
hot points around the electrode and if covered by saline
affect the temperature distribution around the electrode,
including the 100 C isotherm ring closure that precedes roll-
off. This geometry is also probably responsible for the CZ
diameter being 0.06 cm smaller than the spherical geometry,
as its radial distance was slightly smaller than the spherical
radius. This difference was higher (0.18 cm) when both geo-
metries were compared in the models that included a
tumour (E and F).
Additional observation of the Joule heat source distribu-
tion showed that the metal infusion needle could act as a
passive electrode by focussing the electrical current and
hence “build” a radius of a greater power deposition than
would be the case with only the active electrode working.
This could therefore affect the current distribution in tissue
and the volume of the power deposition by the Joule effect.
The temperature profile and the CZ size could therefore be
increased by this factor. Also, a higher power intensity seen
at the borders of the tumour and saline domains would sug-
gest that the power deposition occurs faster at the borders
than within the domain but since this difference does not
correlate with the corresponding temperature distribution
this hypothesis is discarded. Thus, the most likely reason
would be the boundary effect produced between two neigh-
bouring domains with different electrical properties (see
cases A vs. B–D and B–D vs. E–F).
Apart from the small differences between cases E and F,
the general conclusion is that the three-compartment models
offered the most similar results to those of the clinical trial in
terms of impedance evolution (see Figure 3) and CZ diame-
ters (see Figure 6).
4.1. Limitations of the study
Because the in vivo study did not consider application of RF
power nor tumour tissue we cannot be certain of the saline
distribution in these circumstances. However, it is generally
accepted that a tumour has an unorganised, disfigured and
leaky vessel network with insufficient blood supply, so that
its vessel system seems unlikely to be a preferential path of
saline drainage [51]. The authors consider that saline would
tend to accumulate in the tumour, or at least there would
be no significant mechanisms to drain saline away from the
tumour, which would justify the assumption of static saline
distribution in the model. This is in line with the observa-
tions during the clinical trials on actual cases of hepatic
tumours, in which no roll-offs occurred after the bolus injec-
tions, unlike RFA with saline infusion on healthy tissue.
We recognise that RF-induced heating could affect tissue
properties and modify saline distribution. First of all, protein
denaturation is known to increase tissue permeability in the
ablated region, but this may not be the case further away
from the electrode. This would imply saline migration to
more permeable regions. However, the denatured tissue sur-
rounding the electrode would shrink, allowing saline retained
at the more permeable zone to move closer to the electrode.
There is also a possibility that the nearby blood vessels
would narrow or close completely due to the high tempera-
ture and eliminate this preferential saline path. In other
words, during RFA the saline distribution could change due
to vaporisation but would remain in the area of infusion as
there would be no paths for the saline to drain.
The computer model did not consider the possible add-
itional thermal damage associated with vapour migration
after the boiling of interstitial liquids, which can affect CZ
size [52]. The increased vapour volume means that in order
to stay in thermodynamic equilibrium it needs to expand to
maintain the same interstitial pressure, as otherwise, if the
volume is constrained, the pressure would increase and the
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saline could move away from this region. In any case, hot
saline transport or vapour migration could engender sub-
stantial damage in the surrounding tissue [52] and conse-
quently would modify the CZ size. This phenomenon has
been reported to be important in cases with high energy
delivery (>100 kJ) for a long period (>30min) [52]. Because
in our case the delivered energy was 30 kJ, we consider
that the pressure level was not high enough to cause signifi-
cant saline or vapour migration.
It is also important to point out that the factor F used in
this study did not really model the specific phenomena trig-
gered by tissue hydration, such as the higher tissue heat
capacity, the latent heat throughout ablation and therefore
the longer energy release during the phase change. In this
light, its use has no physical explanation. Instead, it was
included simply as an adjusting parameter whose value was
obtained in a previous study by means of sensitivity analysis,
in response to the greater energy requirement when consid-
ering saline infusion [13]. The phase change due to water
vaporisation could also be modelled using the apparent heat
capacity method, which defines the increased heat capacity
over a transition phase as a function of temperature. This
would describe the evaporation mechanism more precisely
and would be more suitable for modelling vaporisation with
this type of electrode. On the other hand, neither the
enthalpy method nor the apparent heat capacity method
includes the effect of vapour heat migration, since they
assume it to be small. Our approach simplifies the model by
simply adjusting the value of the energy at the phase
change at 99 C instead of defining the transitory state.
Neither does it increase the computational requirements, as
in the apparent heat capacity method that uses smaller time
step and greater mesh refinement.
With regard to the model, the axial symmetry could be a
limitation as it involved using the same value for both trans-
versal diameters of the modelled tumour. Although real
tumour nodules present three different axis diameters, the
results are still valid since we used the same diameter for
both modelling the tumour and assessing the CZ diameter.
5. Conclusions
Our experimental findings suggest that the saline spatial dis-
tribution in healthy tissue is not necessarily spherical. In fact,
saline tends to cumulate around the outlets of the infusion
needles, forming an oval-like geometry with the largest
diameter in the direction of the electrode axis. The computer
modelling study suggests that the inclusion of a second
compartment (tumour or infused saline) involves a reduction
of the initial impedance and larger coagulation zone size
than a one-compartment model based on healthy tissue. The
only results similar to the clinical trials were obtained from
the three-compartment models (including healthy liver,
tumour with noninfused and saline-infused zones) in terms
of impedance evolution and CZ diameters. Adding these two
features could thus help to develop a more precise and clin-
ically oriented computer model.
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